OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis | MicrobiomeTrials← Back to trialsNCT06355934
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-08-21Est. Completion: 2026-11-02
Enrollment target: 52,121 participants Locations- Research Site, Eden Prairie, Minnesota, United States
- Research Site, Calgary, Alberta, Canada
- Research Site, Beijing, China
- Research Site, Changsha, China
- Research Site, Chengdu, China
- Research Site, Guangzhou, China
- Research Site, Wuhan, China
- Research Site, Horsens, Denmark
- Research Site, Berlin, Germany
- Research Site, Lecce, Italy
- Research Site, Messina, Italy
- Research Site, Milan, Italy
- Research Site, Tokyo, Japan
- Research Site, Lisbon, Portugal
- Research Site, Porto, Portugal
- Research Site, A Coruña, Spain
- Research Site, Barcelona, Spain
- Research Site, Bilbao, Spain
- Research Site, El Palmar, Spain
- Research Site, Huelva, Spain
- Research Site, Las Palmas de Gran Canaria, Spain
- Research Site, Madrid, Spain
Other microbiome trials you might be interested in
Transthyretin Amyloid Cardiomyopathy
Transthyretin (TTR) is a protein made by the liver that helps transport thyroid hormone and vitamin A in the blood. In s…
Sankt Pölten, AustriaEst. completion Jul 15, 2027
Transthyretin Amyloidosis With Cardiomyopathy
The purpose of this study is to:
* Describe the clinical characteristics of adult patients with transthyretin-mediated …
Tucson, United StatesEst. completion Oct 23, 2030
Research Site, Majadahonda, SpainResearch Site, Palma de Mallorca, SpainResearch Site, Salamanca, SpainResearch Site, Valencia, SpainResearch Site, Södertälje, SwedenResearch Site, Umeå, SwedenResearch Site, London, United Kingdom